An Update on Patent Ductus Arteriosus and What is Coming Next

ERDEVE Ö., OKULU E., Singh Y., Sindelar R., Oncel M. Y., Terrin G., ...Daha Fazla

TURKISH ARCHIVES OF PEDIATRICS, cilt.57, sa.2, ss.118-131, 2022 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 57 Sayı: 2
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5152/turkarchpediatr.2022.21361
  • Dergi Adı: TURKISH ARCHIVES OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.118-131
  • Anahtar Kelimeler: patent ductus arteriosus, preterm, conservative, medical, surgical, treatment, INTENSIVE-CARE-UNIT, NEONATOLOGIST-PERFORMED ECHOCARDIOGRAPHY, EXTREMELY PRETERM INFANTS, URINARY NT-PROBNP, BIRTH-WEIGHT, PREMATURE-INFANTS, CONTROLLED-TRIAL, ORAL IBUPROFEN, INTRAVENTRICULAR HEMORRHAGE, NEURODEVELOPMENTAL OUTCOMES
  • Ankara Üniversitesi Adresli: Evet

Özet

Patent ductus arteriosus is the most common cardiovascular condition in preterm infants. There is a significant uncertainty about when and how to close ductus arteriosus in preterm infants due to a high spontaneous closure rate even in very immature preterm infants. Diagnosis and management of patent ductus arteriosus remain a challenge for both neonatologists and pediatric cardiologists. Researchers have tried to define a balance between an expectant approach and active treatment in selected infants. This review aimed to focus on the pathophysiology and management of patent ductus arteriosus and to make suggestions about approaches that might eliminate the association of morbidities with patent ductus arteriosus.